Skip to content
Screener

Thermo Fisher Scientific TMO Treasury stock, value, acquired

Treasury stock, value, acquired at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$12.0B
Operating income$2.1B
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$214.46B+26.5%
Enterprise value$249.58B+23.3%
P/E30.8×+5.0×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockValueAcquiredCostMethod.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000097745-26-000092
(In millions)Redeemable Noncontrolling InterestCommon Stock / Shares / Three months ended March 28, 2026Common Stock / Amount / Three months ended March 28, 2026Capital in Excess of Par Value / Three months ended March 28, 2026Retained Earnings / Three months ended March 28, 2026Treasury Stock / Shares / Three months ended March 28, 2026Treasury Stock / Amount / Three months ended March 28, 2026Accumulated Other Comprehensive Income/(Loss) / Three months ended March 28, 2026Total Thermo Fisher Scientific Inc. Shareholders’ Equity / Three months ended March 28, 2026Noncontrolling Interests / Three months ended March 28, 2026Total Equity / Three months ended March 28, 2026
Balance at December 31, 2025$122445$445$18,563$59,15669$(22,309)$(2,448)$53,407$7$53,415
Issuance of shares under stock plans66(22)4444
Stock-based compensation838383
Purchases of company common stock5(3,000)(3,000)(3,000)
Dividends declared ($0.47 per share)(175)(175)(175)
Net income/(loss)41,6511,6511,651
Other comprehensive income/(loss)(6)(49)(49)(49)
Contributions from (distributions to) noncontrolling interest(1)(1)

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's treasury stock, value, acquired?
Thermo Fisher Scientific (TMO) reported treasury stock, value, acquired of $3B in Q1 2026.
How has Thermo Fisher Scientific's treasury stock, value, acquired changed year-over-year?
Thermo Fisher Scientific's treasury stock, value, acquired increased by 50.0% year-over-year, from $2B to $3B.

Ask your AI about Thermo Fisher Scientific's treasury stock, value, acquired.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude